Serge Berger

Serge Berger

InvestorPlace Contributor

Serge Berger is the Head Trader and Investment Strategist for The Steady Trader.

He has been an active trader since 1998. During his career, he has been a financial analyst, dealt in fixed income instruments at JPMorgan, and was a proprietary trader in equity options and futures. Having exposure to a range of different asset classes allowed him to identify which asset classes and strategies best fit his goal of achieving consistent profits.

Over the years, he created a trading methodology that divides markets into different time frames and characters, allowing him to determine which strategies to apply in which situations without emotion. By focusing on only the highest probability trading setups, Serge maximizes overall profitability and minimizes stress and volatility.

Follow him on Twitter via @SteadyTrader.

Recent Articles

Trade of the Day: The Corrective Period in Square Inc Stock May Be Over

By Serge Berger, InvestorPlace Contributor

Last week's strong rally in SQ stock followed a six-week consolidation phase, and now Square bulls look firmly in charge.

Trade of the Day: UnitedHealth Group Is Waving Down the Bulls

By Serge Berger, InvestorPlace Contributor

So far in January, UnitedHealth stock has lagged the healthcare rally but UNH looks increasingly giddy for a breakout.

Trade of the Day: Micron Technology, Inc. Could Be the Next Breakout

By Serge Berger, InvestorPlace Contributor

Through a multiweek/month lens a next leg higher in MU stock and other semiconductor stocks may just be getting underway.

Trade of the Day: Netflix, Inc. Kicks Off the New Year With a Bang

By Serge Berger, InvestorPlace Contributor

On Jan. 2, NFLX stock completed the first leg of a breakout that Netflix traders and investors could now look to sink their teeth into.

Three Important Stock Charts to Kick Off 2018

By Serge Berger, InvestorPlace Contributor

To kick off 2018, here are three important charts to gain perspective on stocks and commodities. The year will have plentiful opportunities for the patient market participant.

Load More